DiscoverBridges - Advances in Cancer TherapeuticsEpisode 2 - The future is now-combination therapies in DLBCL
Episode 2 - The future is now-combination therapies in DLBCL

Episode 2 - The future is now-combination therapies in DLBCL

Update: 2025-11-24
Share

Description

Interested in novel combination therapies for patients with diffuse large B-cell lymphoma (DLBCL)? Dr. Marie Hu joins the podcast to share her perspectives on emerging treatments and the impact of stronger academic-community collaborations on patient care for relapsed and refractory patients with DLBCL.

Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graff, MD, Mission Cancer & Blood
Guest: Dr. Marie Hu, Assistant Professor of Medicine, University of Minnesota

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 2 - The future is now-combination therapies in DLBCL

Episode 2 - The future is now-combination therapies in DLBCL

ADC Therapeutics